MRK Jan 2025 82.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:03PM EDT. Market open.
| Previous Close | 40.95 |
| Open | 40.95 |
| Bid | 43.00 |
| Ask | 47.25 |
| Strike | 82.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 40.95 - 40.95 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 56 |
Business WireMerck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
RAHWAY, N.J., May 15, 2024--Merck to Present New Data at 2024 ASCO Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
ZacksMerck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Merck (MRK) discontinues the Keytruda plus vibostolimab co-formulation arm of a phase III study due to a higher rate of patient discontinuation.
Business WireMerck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma
RAHWAY, N.J., May 13, 2024--Merck Update on KeyVibe-010 Evaluating Coform of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients W/ Resected High-Risk Melanoma
© 2024 Yahoo. All rights reserved.